ConductScience.org, home

Paper8945688

Characteristics of materials distributed by drug companies. An evaluation of appropriateness.

Stryer D and 1 other. J Gen Intern Med, 1996. Cited by 72 papers, by iCite.

Cite this record

ConductScience Library. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. Papers, record 8945688. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8945688

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characteristics of materials distributed by drug companies. An evaluation of appropriateness.
PubMed
Journal
J Gen Intern Med
PubMed
Year
1996
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
2.18
iCite
Revised in PubMed
2022-04-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stryer DD
2Bero LAL A

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AttitudeMajor topic
Drug IndustryMajor topic
Information DisseminationMajor topic
Interprofessional RelationsMajor topic
United States Food and Drug AdministrationMajor topic
Advertising
Conflict of Interest
Cross-Sectional Studies
Drug Utilization
Government Regulation
Humans
Sampling Studies
United States

Source PubMed

Download CSV of topics

Comments and corrections4

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in8945696Pharmaceutical marketing has real and proven value. Characteristics of materials distributed by drug companies: four points of view.https://conductscience.org/library/papers/8945696PubMed
Comment in8945697Why do American drug companies spend more than $12 billion a year pushing drugs? Is it education or promotion? Characteristics of materials distributed by drug companies: four points of view.https://conductscience.org/library/papers/8945697PubMed
Comment in8945698Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view.https://conductscience.org/library/papers/8945698PubMed
Comment in8945699Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view.https://conductscience.org/library/papers/8945699PubMed

Download CSV of comments and corrections

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17935706Therapeutic-class wars--drug promotion in a competitive marketplace.N Engl J Med1994https://conductscience.org/library/papers/7935706PubMed
21620175Pharmaceutical promotions--a free lunch?N Engl J Med1992https://conductscience.org/library/papers/1620175PubMed
37715044The accuracy of drug information from pharmaceutical sales representatives.JAMA1995https://conductscience.org/library/papers/7715044PubMed
46130249"Opren scandal".Lancet1983https://conductscience.org/library/papers/6130249PubMed
57395709Keeping prescription drug advertising honest. FDA's watchful eye.Am Pharm1980https://conductscience.org/library/papers/7395709PubMed
68413431A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients.N Engl J Med1993https://conductscience.org/library/papers/8413431PubMed
71999900The FDA and drug marketing expenditures.JAMA1991https://conductscience.org/library/papers/1999900PubMed
81620188Education or promotion?N Engl J Med1992https://conductscience.org/library/papers/1620188PubMed
98541768Analysis of the bureaucratic unsolicited mountainous paper heap (BUMPH) that general practitioners received in 1994.BMJ1995https://conductscience.org/library/papers/8541768PubMed
102231998The federal regulation of prescription drug advertising and promotion.JAMA1990https://conductscience.org/library/papers/2231998PubMed
112301192Impact of a drug bulletin on the knowledge, perception of drug utility, and prescribing behavior of physicians.DICP1990https://conductscience.org/library/papers/2301192PubMed
128214998The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.Ann Intern Med1993https://conductscience.org/library/papers/8214998PubMed
137504540Pertussis immunisation and serious acute neurological illnesses in children.BMJ1993https://conductscience.org/library/papers/7504540PubMed
142583883Doctors and detailers: therapeutic education or pharmaceutical promotion?Int J Health Serv1989https://conductscience.org/library/papers/2583883PubMed
157901473Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial.Lancet1993https://conductscience.org/library/papers/7901473PubMed
168214997Treatment of rheumatoid arthritis with gammalinolenic acid.Ann Intern Med1993https://conductscience.org/library/papers/8214997PubMed
178324433Interactions between a general practitioner and representatives of drug companies.BMJ1993https://conductscience.org/library/papers/8324433PubMed
188411572An economic evaluation of screening for Chlamydia trachomatis in adolescent males.JAMA1993https://conductscience.org/library/papers/8411572PubMed
191728655Policies regulating the activities of pharmaceutical representatives in residency programs.J Fam Pract1992https://conductscience.org/library/papers/1728655PubMed
206637804The regulation of prescription drug advertising.Am Pharm1983https://conductscience.org/library/papers/6637804PubMed

See all 45 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
31440103Critical evaluation of the validity of drug promotion materials in Ethiopia.Drug Healthc Patient Saf2019https://conductscience.org/library/papers/31440103PubMed
28664660Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?Br J Clin Pharmacol2017https://conductscience.org/library/papers/28664660PubMed
23432773The cycle of bias in health research: a framework and toolbox for critical appraisal training.Account Res2013https://conductscience.org/library/papers/23432773PubMed
23093870Evaluation of drug promotional materials in a hospital setting in Nepal.South Med Rev2009https://conductscience.org/library/papers/23093870PubMed
22745328High reprint orders in medical journals and pharmaceutical industry funding: case-control study.BMJ2012https://conductscience.org/library/papers/22745328PubMed
21206615Evaluation of rationality of promotional drug literature using World Health Organization guidelines.Indian J Pharmacol2010https://conductscience.org/library/papers/21206615PubMed
17455990Characteristics and impact of drug detailing for gabapentin.PLoS Med2007https://conductscience.org/library/papers/17455990PubMed
16927162Point-counterpoint: the importance of "open access" to psychotropics for our patients.Psychiatr Q2006https://conductscience.org/library/papers/16927162PubMed
16861873Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia.Ann Saudi Med2006https://conductscience.org/library/papers/16861873PubMed
16050893Interactions between pharmaceutical representatives and doctors in training. A thematic review.J Gen Intern Med2005https://conductscience.org/library/papers/16050893PubMed
15994365Autonomy, consent, and limiting healthcare costs.J Med Ethics2005https://conductscience.org/library/papers/15994365PubMed
14694885[Psychiatrists and the pharmaceutical industry].Nervenarzt2003https://conductscience.org/library/papers/14694885PubMed
12759794Prescribing information in 26 countries: a comparative study.Eur J Clin Pharmacol2003https://conductscience.org/library/papers/12759794PubMed
11885831Selling drugs to the public--should the UK follow the example of the US?Br J Gen Pract2002https://conductscience.org/library/papers/11885831PubMed
11885830Selling drugs to doctors--it's marketing, not education.Br J Gen Pract2002https://conductscience.org/library/papers/11885830PubMed
11381005"Educational" advertisements--I haven't seen one yet!West J Med2001https://conductscience.org/library/papers/11381005PubMed
10578674Pharmaceutical advertising revenue and physician organizations: how much is too much?West J Med1999https://conductscience.org/library/papers/10578674PubMed
10323794Direct to consumer advertising of prescription drugs. An idea whose time should not come.BMJ1999https://conductscience.org/library/papers/10323794PubMed
8945699Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view.J Gen Intern Med1996https://conductscience.org/library/papers/8945699PubMed
8945698Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view.J Gen Intern Med1996https://conductscience.org/library/papers/8945698PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8945688

GET https://conductscience.org/api/papers/v1/8945688/references?page=2